Barrington Strategic Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$1.52M Sell
44,894
-532
-1% -$17.1K 0.77% 35
2017
Q2
$1.45M Sell
45,426
-496
-1% -$15.6K 0.74% 36
2017
Q1
$1.49M Sell
45,922
-1,844
-4% -$58.1K 0.78% 35
2016
Q4
$1.47M Sell
47,766
-185
-0.4% -$5.65K 0.79% 36
2016
Q3
$1.54M Buy
47,951
+5,403
+13% +$181K 0.87% 35
2016
Q2
$1.42M Sell
42,548
-1,412
-3% -$45.1K 0.81% 37
2016
Q1
$1.24M Sell
43,960
-817
-2% -$23.3K 0.72% 40
2015
Q4
$1.37M Sell
44,777
-401
-0.9% -$12.6K 0.8% 35
2015
Q3
$1.35M Sell
45,178
-186
-0.4% -$5.96K 0.86% 38
2015
Q2
$1.44M Buy
45,364
+184
+0.4% +$6K 0.87% 38
2015
Q1
$1.49M Sell
45,180
-121
-0.3% -$3.85K 0.91% 36
2014
Q4
$1.34M Buy
45,301
+1,189
+3% +$34.1K 0.86% 36
2014
Q3
$1.24M Sell
44,112
-221
-0.5% -$6.2K 0.8% 39
2014
Q2
$1.25M Buy
44,333
+433
+1% +$12.3K 0.79% 44
2014
Q1
$1.34M Buy
43,900
+84
+0.2% +$2.5K 0.87% 38
2013
Q4
$1.27M Buy
43,816
+940
+2% +$27.4K 0.85% 38
2013
Q3
$1.17M Buy
42,876
+964
+2% +$26.2K 1.04% 36
2013
Q2
$1.11M Buy
+41,912
New +$1.16M 0.92% 38

Other funds holding PFE

Barrington Strategic Wealth Management Group's PFE Position: Q3 2017 in Review

Barrington Strategic Wealth Management Group reduced its Pfizer (PFE) stake by 1.2% in Q3 2017, selling an estimated $17.1K and leaving 44,894 shares worth $1.52M. The position accounts for 0.77% of the portfolio, ranked #35.

Barrington Strategic Wealth Management Group first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. The position peaked at $1.54M in Q3 2016. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • Barrington Strategic Wealth Management Group held 44,894 shares of Pfizer worth $1.52M as of Q3 2017.
  • Barrington Strategic Wealth Management Group sold 532 Pfizer shares in Q3 2017, an estimated $17.1K.
  • Pfizer made up 0.77% of Barrington Strategic Wealth Management Group's portfolio in Q3 2017, its #35 holding.
  • Barrington Strategic Wealth Management Group first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • Barrington Strategic Wealth Management Group's Pfizer position peaked at $1.54M in Q3 2016.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on Barrington Strategic Wealth Management Group's 13F filing for Q3 2017, filed 31 Oct 2017.